Bullfrog AI Appoints Dr. Thomas W. Chittenden as Chief Scientific Officer

BullFrog AI Holdings, Inc.

Dr. Chittenden appointed CSO effective February 26, 2024.
Previously served as CSO and President of R&D at BioAI Health.
Also founded AI/SciML initiative at HiberCell and consulted at Harvard Medical School.
Will lead scientific strategy to advance Bullfrog AI's bfLEAP™ AI drug discovery platform.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.